Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neurobiology of Disease

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nbd.2011.06.007PMID 21726646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme

  2011cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2010cited by this paper
• HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer

  2010cited by this paper
• Mitochondrial functionality in reproduction: from gonads and gametes to embryos and embryonic stem cells.

  2009cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2009cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• Tumor cell metabolism: cancer's Achilles' heel.

  2008cited by this paper
• Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy

  2008cited by this paper
• Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent

  2008cited by this paper
• The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

  2008cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Pyruvate kinase type M2 and its role in tumor growth and spreading.

  2005cited by this paper
• Genome-wide expression dynamics during mouse embryonic development reveal similarities to Drosophila development.

  2005cited by this paper
• Transcript profiling during preimplantation mouse development.

  2004cited by this paper
• Glucose Metabolism in Cancer

  2003cited by this paper
• Involvement of Mitochondria and Other Free Radical Sources in Normal and Abnormal Fetal Development

  2002cited by this paper
• Cell metabolism in the regulation of programmed cell death.

  2002cited by this paper
• Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited.

  2002cited by this paper
• Glucose Catabolism in Cancer Cells

  2001cited by this paper
• Hexokinase II-deficient Mice

  1999cited by this paper
• Developmental expression of hexokinase 1 and 3 in rats

  1997cited by this paper
• High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss.

  1996cited by this paper
• Glucose Catabolism in Cancer Cells.

  1995cited by this paper
• Development of glucose utilization studied in single oocytes and preimplantation embryos from mice.

  1994cited by this paper
• The role of glucose and pyruvate transport in regulating nutrient utilization by preimplantation mouse embryos.

  1988influential reference
• On respiratory impairment in cancer cells.

  1956cited by this paper
• On respiratory impairment in cancer cells.

  1956cited by this paper

• Metabolic reprogramming and immunosenescence: a new sight for glioma therapy

  2026influential citation
• Metabolic reprogramming and epigenetic effects due to reducing sugars and glycation products in cancer

  2026cites this paper
• Metabolic adaptations in cancer progression.

  2025cites this paper
• Signaling Pathways in Gliomas

  2025cites this paper
• Investigation of the Neurotoxicity Mechanisms of Ni2+ in Rat Neocortical Neurons Through Transcriptome Analysis

  2025cites this paper
• Metabolic and epigenetic dysregulation in IDH1/2-mutant gliomas: A microglial-mediated mechanism of blood-brain barrier disruption.

  2025cites this paper
• Diversity of metabolic features and relevance to clinical subtypes of gliomas.

  2025cites this paper
• Epigenetic Control of Redox Pathways in Cancer Progression

  2025cites this paper
• CADD-based discovery of novel oligomeric modulators of PKM2 with antitumor activity in aggressive human glioblastoma models

  2025cites this paper
• C11orf53 Promotes the Progression of Small Cell Lung Cancer by Regulating Glucose Metabolism

  2025cites this paper
• Dual Regulation Mechanism of Obesity: DNA Methylation and Intestinal Flora

  2024cites this paper
• Notch signaling pathway suppresses mRNA expression of hexokinase 2 under nutrient‐poor conditions in U87‐MG glioma cells

  2024cites this paper
• Epigenetic regulation in cancer

  2024cites this paper
• DNA 5mC and RNA m^6A modification successively facilitates the initiation and perpetuation stages of HSC activation in liver fibrosis progression

  2023cites this paper
• Metabolic Profiles Point Out Metabolic Pathways Pivotal in Two Glioblastoma (GBM) Cell Lines, U251 and U-87MG

  2023influential citation
• Metabolic Rewiring in Adult-Type Diffuse Gliomas

  2023cites this paper
• U3 snoRNA‐mediated degradation of ZBTB7A regulates aerobic glycolysis in isocitrate dehydrogenase 1 wild‐type glioblastoma cells

  2023cites this paper
• Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease

  2023cites this paper
• Metabolic Barriers to Glioblastoma Immunotherapy

  2023cites this paper
• Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme

  2023cites this paper
• Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy

  2022cites this paper
• DNA Methylation: From Cancer Biology to Clinical Perspectives.

  2022cites this paper
• TET2 deficiency sensitizes tumor cells to statins by reducing HMGCS1 expression.

  2022cites this paper
• Modulation of DNA/RNA Methylation Signaling Mediating Metabolic Homeostasis in Cancer.

  2022cites this paper
• Reprogramming Carbohydrate Metabolism in Cancer and Its Role in Regulating the Tumor Microenvironment.

  2022cites this paper
• Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities

  2022cites this paper
• Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis

  2022cites this paper
• Nociceptor-derived Reg3γ prevents endotoxic death by targeting kynurenine pathway in microglia.

  2022cites this paper
• Hexokinase-2-Linked Glycolytic Overload and Unscheduled Glycolysis—Driver of Insulin Resistance and Development of Vascular Complications of Diabetes

  2022cites this paper
• F-box protein 17 promotes glioma progression by regulating glycolysis pathway.

  2022cites this paper
• Long Noncoding RNAs and Human Cancer

  2021cites this paper
• Targeting CDK9 for the Treatment of Glioblastoma

  2021cites this paper
• Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer

  2021cites this paper
• The Role of Thyroid Hormone in Neuronal Protection.

  2021cites this paper
• Glioma glycolipid metabolism: MSI2–SNORD12B–FIP1L1–ZBTB4 feedback loop as a potential treatment target

  2021cites this paper
• Biosynthesis of magnesium hydroxide nanomaterials using Monodora myristica, antioxidative activities and effect on disrupted glucose metabolism in streptozotocin-induced diabetic rat

  2021cites this paper
• Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship.

  2021cites this paper
• Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation

  2021cites this paper
• Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis

  2021cites this paper
• Stress Responses as Master Keys to Epigenomic Changes in Transcriptome and Metabolome for Cancer Etiology and Therapeutics

  2021cites this paper
• Metabolic regulation in urological tumors: Interplay with epigenetics and epitranscriptomics

  2021cites this paper
• Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer

  2021cites this paper
• High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates With Lower Survival

  2021cites this paper
• Metabostemness in cancer: Linking metaboloepigenetics and mitophagy in remodeling cancer stem cells

  2021cites this paper
• MicroRNA-216b targets HK2 to potentiate autophagy and apoptosis of breast cancer cells via the mTOR signaling pathway

  2021cites this paper
• EVALUATING THE EFFECTS OF FASTING CONDITIONS IN COMBINATION WITH TEMOZOLOMIDE FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

  2020cites this paper
• How DNA methylation affects the Warburg effect

  2020cites this paper
• Exploring the crosstalk of glycolysis and mitochondrial metabolism in psychiatric disorders and brain tumours

  2020cites this paper
• THE PEPTIDOGLYCAN FRACTION ENRICHED WITH MURAMYL PENTAPEPTIDE FROM Lactobacillus bulgaricus INHIBITS GLIOBLASTOMA U373MG CELL MIGRATION CAPABILITY AND UPREGULATES PARP1 AND NF-kB LEVELS

  2020cites this paper
• Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer

  2020cites this paper
• Modulation of dysregulated cancer metabolism by plant secondary metabolites: A mechanistic review.

  2020cites this paper
• Causes and Consequences of Variable Tumor Cell Metabolism on Heritable Modifications and Tumor Evolution

  2020cites this paper
• Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression

  2019cites this paper
• Inhibition of glycolytic metabolism in glioblastoma cells by Pt3glc combinated with PI3K inhibitor via SIRT3‐mediated mitochondrial and PI3K/Akt–MAPK pathway

  2019cites this paper
• Epigenetic modulation of metabolism in glioblastoma.

  2019cites this paper
• The Implication of Anti-angiogenic Treatment of Malignancies on Human Metabolism

  2019cites this paper
• Connections between metabolism and epigenetics in cancers.

  2019cites this paper
• Hexokinase-2 Glycolytic Overload in Diabetes and Ischemia-Reperfusion Injury.

  2019cites this paper
• Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance

  2019cites this paper
• Mechanisms and Implications of Metabolic Heterogeneity in Cancer.

  2019cites this paper
• RETRACTED ARTICLE: Myricetin nanoliposomes induced SIRT3-mediated glycolytic metabolism leading to glioblastoma cell death

  2018cites this paper
• Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells

  2018cites this paper
• Anti-fibrosis activity of combination therapy with epigallocatechin gallate, taurine and genistein by regulating glycolysis, gluconeogenesis, and ribosomal and lysosomal signaling pathways in HSC-T6 cells

  2018cites this paper
• Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets

  2018cites this paper
• Caveolin enhances hepatocellular carcinoma cell metabolism, migration, and invasion in vitro via a hexokinase 2‐dependent mechanism

  2018cites this paper
• DNMT1 mediates metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma

  2018cites this paper
• Temporal Changes in Cortical and Hippocampal Expression of Genes Important for Brain Glucose Metabolism Following Controlled Cortical Impact Injury in Mice

  2017cites this paper
• Novel Targeting of Transcription and Metabolism in Glioblastoma

  2017cites this paper
• Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway

  2017cites this paper
• Imaging and Metabolism

  2017influential citation
• Interplay between mitochondrial metabolism and oxidative stress in ischemic stroke: An epigenetic connection.

  2017cites this paper
• Metabolic Reprogramming in Brain Tumors.

  2017cites this paper
• Role of AHR and HIF-1 a in Glioblastoma Metabolism

  2017cites this paper
• Overexpression of Hexokinase 1 as a poor prognosticator in human colorectal cancer

  2016cites this paper
• Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma

  2016cites this paper
• The intersection between aerobic glycolysis, cerebellar neurogenesis, and medulloblastoma

  2016cites this paper
• Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.

  2016influential citation
• Inhibition of Lung Carcinoma A549 Cell Growth by Knockdown of Hexokinase 2 In Situ and In Vivo

  2016cites this paper
• Non-invasive metabolic imaging of brain tumours in the era of precision medicine

  2016cites this paper
• Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma.

  2016cites this paper
• Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma

  2016influential citation
• Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma

  2016cites this paper
• The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes

  2015cites this paper
• Brain Tumor Metabolism — Unraveling Its Role in Finding New Therapeutic Targets

  2015influential citation
• Enzymes of the central carbon metabolism: are they linkers between transcription, DNA replication, and carcinogenesis?

  2015cites this paper
• The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.

  2015cites this paper
• Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments.

  2015cites this paper
• Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma

  2015cites this paper
• Epigenetics and cancer metabolism.

  2015cites this paper
• Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations

  2015cites this paper
• Redox-based epigenetic status in drug addiction: a potential contributor to gene priming and a mechanistic rationale for metabolic intervention

  2015cites this paper
• Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.

  2014cites this paper
• Interplay between epigenetics & cancer metabolism.

  2014cites this paper
• Dual proteolytic pathways govern glycolysis and immune competence.

  2014cites this paper
• Targeting SREBP-1-driven lipid metabolism to treat cancer.

  2014cites this paper
• Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma

  2014cites this paper
• Emerging Anti-cancer Targets in Mitochondria

  2014cites this paper
• IDH1 regulates phospholipid metabolism in developing astrocytes.

  2014cites this paper
• Metabostemness: A New Cancer Hallmark

  2014cites this paper
• Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma.

  2014cites this paper